RTI Surgical Has a New Chief Commercial Officer

UF startup and UF Innovate | Accelerate graduate company RTI Surgical announced it appointed Chad Croasdale as chief commercial officer.

Croasdale has more than 20 years of commercial and financial experience in the medtech industry. He will oversee the tissue reconstruction company’s growth strategy and corporate development.

“We are delighted to welcome Chad to RTI. His extensive experience in driving commercial success will be invaluable as we continue to establish ourselves as the CDMO partner of choice in regenerative medicine, leveraging our unique portfolio of xenograft and allograft biomaterials to improve patient outcomes,” President and CEO Olivier Visa said in a news release.

Read more about RTI Surgical Has a New Chief Commercial Officer.